Tetracyclic compounds and their salts, compositions, and methods for their use
PH12022550360B1Active Publication Date: 2026-11-06SENHWA BIOSCIENCES INC
0 Cites 0 Cited by
Patent Information
- Application Number
- PH12022550360
- Authority / Receiving Office
- PH · PH
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2022-02-14
- Publication Date
- 2026-11-06
- Estimated Expiration
- 2042-02-14
Abstract
The present invention includes 2-(4-Methyl-[1,4]diazepan-1-yl)-5-oxo-5H-7-thia1,11b-diaza-benzo[c]fluorene-6-carboxylic acid (5-methyl-pyrazin-2-ylmethyl)-amide (Compound I) or a pharmaceutically acceptable salt thereof for use in treating cancer with PALB2 mutation and / or BRCA2 mutation.
Need to check novelty before this filing date? Find Prior Art
